AI-driven breakthroughs are accelerating drug discovery, transforming diagnostics, and pushing the boundaries of precision medicine. Quantum computing is advancing toward commercialization, with the potential to reshape molecular modeling and therapeutic development. Canada has the research leadership, deep technology capabilities, and growing private capital interest to turn these advancements into global competitive advantages—but the question is how investors can position themselves to capture the upside.

This webinar, presented in partnership with BIOTECanada, brings together leading investors to explore where innovation and technology have already generated returns in life sciences, how biotech investment models are evolving, and what private capital needs to do now to stay ahead of the next wave of disruption. With drug development cycles shortening, computational breakthroughs unlocking new IP, and a shift from one-drug companies to biotech platforms, this discussion will focus on the real investment opportunities that will define the next decade of life sciences.

Register Here

The webinar is free for everyone, will be live-streamed on our LinkedIn and also available to watch after on our website.